Skip to Main Content

Paper Details

Establishment and validation of preclinical models of SMARCA4-inactivated and ARID1A/ARID1B co-inactivated dedifferentiated endometrial carcinoma.
Gynecol Oncol
0
2023
(MMR)-deficient DDEC, ARID1A, ARID1B, DDEC, DDEC models, DDEC tumor, DDECs, Dedifferentiated endometrial cancer, GSK-J4, KDM6A, KDM6A/B, MMR-deficient, PDX models, PDX tumors, SMARCA4, SMARCA4-deficienct, SMARCA4-deficient, SMARCA4-deficient cancer, SMARCA4-deficient cell line, SNF, SWI, SWItch, Sucrose, cell line, dedifferentiated endometrial carcinoma, endometrial cancer, mice, patient, patient tumor-derived models, tumor, tumors
Author NameAffiliation
Anne Haegert
Stanislav V Volik
Colin C Collins
Andreas von DeimlingHeidelberg University Hospital and CCU Neuropathology DKFZ
Hui Xue
Yuzhuo Wang
Martin K??belCalgary Laboratory Services and University of Calgary
Martin K??belCalgary Laboratory Services and University of Calgary
  • 1 - 8

Datasets

Release 1.2